Jeffrey Vacirca was elected president of the Community Oncology Alliance for a one year term starting Jan. 1.
Vacirca is the CEO and managing partner/director of clinical research at New York Cancer Specialists in Long Island, NY.
In addition to Vacirca, new executive committee officers and members of the board of directors were elected.
A complete and updated list of Officers and Board members can be viewed here.
By law, the Food and Drug Administration is required to determine whether a drug, device, biologic, or medical device is “safe and effective.” But the FDA determination does not control whether the Centers for Medicare & Medicaid Services will pay for it. To satisfy CMS, medical products and services must be “reasonable and necessary,” meaning...
As a radiation oncologist, I am struck by how often the decisive variable in lung cancer is not the sophistication of our therapy, but the timing of our encounter with the disease. The American Cancer Society projects 618,120 cancer deaths in the United States in 2025, with lung cancer remaining as the single largest contributor,...
